Gene vaccination for hepatitis C

Bos JD, Kapsenberg ML (1993) The skin immune system: progress in cutaneous biology. Immunol Today 14: 75 Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unumaaz D, Weiner AJ, Choo QL, Shuster JR, Kuo G, Bonino F, Houghton M, Abrigiani S (1993) T lymphocyte response to hepatitis C virus in clinical courses of infection. Gastroenterology 104: 580 Cahour A (1995) Les perspectives d'un vaccin contre l'hépatite C: quelle stratégie adopter? Méd Sci 11: 81 Davis HL, Michel LM, Whalen RG (1993) DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet 3: 1847 Delpeyroux F, Chenciner N, Lim A, Malpiece Y, Blondel B, Crainic R, Streeck RE (1986) A poliovirus neutralizing epitope expressed, on hybrid hepatitis B surface antigen particles. Science 233: 472 Dietzschold B, Wang H, Rupprecht CE, Celis F, Tollis M, Ertl H, Heber-Katz E, Koprowski H (1987) Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc Natl Acad Sci USA 84: 9165 Dubuisson HJ, Hsu H, Cheung RC, Greenberg HB, Russell DC, Rice CM (1994) Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol 68: 6147 Dubuisson J, Rice CM (1996) Hepatitis C. virus glycoprotein folding; disulfide bond formation and association with calnexi. J Virol 70: 778 Enomoto N, Kuosaki M, Tanaka Y, Marumo F, Sato C (1994) Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J Gen Virol 75: 1361 Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Desai SM, Miller RH, Ogata N, Purcell RH (1992) Lack of protective immunity against reinfection with hepatitis C virus. Science 258: 135 Farci P, Shimoda A, Wong D, Cabezon T, De Gionnis D, Srazzera A, Shimizu Y, Shapiro M, Alter HJ, Purcell RH (1996) Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 93: 15394 Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schienchi C, Missale G, Garcia Marin M, Fiaccadori F (1994) T cell response to structural and non-structural hepatitis C virus antigen in persistent and self-limited hepatitis C virus infection. Hepatology 19: 286 Geissler M, Gesien A, Tokushige K, Wands JR (1997) Enhancement of cellular and Immoral immune responses to hepatitis C virus (HCV) core protein using DNA based vaccines augmented with cytokine expressing plasmids. Abstracts of the Fourth International meeting on hepatitis C virus and related viruses, Kyoto, Japan, 6–10 March. Fujitsu Aprico, Tokyo, p 41 Higashi Y, Kakumi S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y, Ishikawa TM, Nagai N (1993) Dynamics changes in the E2/NS1 region of hepatitis C virus in vivo. Virology 197: 659 Inchauspé G, Vitviski L, Major ME, Jung G, Spengler U, Maisonnas M, Trépo C (1997) Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T -helper responses following genetic immunization. DNA Cell Biol 16: 185 Iwarson S, Tabor E, Thomas HC, Snoy P, Gerety RJ (1985) Protection against hepatitis B virus infection by immunization with hepatitis B core antigen. Gastroenterology 88: 763 Kato N, Sekiya H, Ootsuyama Y, Nakasawa T, Hijikata M, Ohkoshi S, Shimotohno K (1993) Humoral immune response to the hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 67: 3923 Kato N, Ootsuyama Y, Sekiya H, Ohkoshi S, Nakazawa T, Hijikata M, Shimotohno K (1994) Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol 68: 4776 Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, Sato C (1995) Diversity of quasispecies in various diseases stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 22: 30 Kojima M, Osuga T, Tsuda F, Tanaka T, Okamoto H (1994) Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees. Virology 204: 665 Koshy R, Inchauspé G (1996) Evaluation of hepatitis C virus protein epitopes for vaccine development. Trends Biotechnol 14: 365 Lagging LM, Meyer K, Hoft D, Houghton M, Belshe RB, Ray R (1995) Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J Virol 69: 5859 Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A, Farci P (1994) Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343: 338 Leroux-Roels G, Alvadero Esquivel C, DeLeys R, Stuyver L, Elewaut A, Philippé J, Desombre L, Paradijs J, Maerteens G (1996) Lymphoproliferative responses to hepatitis C virus core, E1, E2 and NS3 in patients with chronic hepatitis C infection treated with interferon alfa. Hepatology 23: 8 Major MM, Vivitski L, Mink MA, Schleef M, Whalen RG, Trépo C, Inchauspé G (1995) DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol 69: 5798 Mast EE, Alter MJ (1993) Epidemiology of viral hepatitis: an overview. Semin Virol 4: 273 Michel ML, Mancini M, Sobczak E, Favier V, Guetard D, Bahraoui EM (1988) Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV-hepatitis B surface antigen particles. Proc Natl Acad Sci USA 85: 7957 Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, Houghton M, Fiaccadori F, Ferrari C (1996) Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral-cell mediated immune responses. J Clin Invest 98: 706 Nakano I, Maertens G, Major ME, Vitvitski L, Dubuisson J, Fournillier A, De Martynoff G, Trépo C, Inchauspé G (1997) Direct injection of HCV-E2 encoding plasmid DNA: induction of antibody responses and dependence on the immunization mode. Abstracts of the Fourth International Meeting on Hepatitis C virus and Related Viruses, Kyoto, Japan, 6–10 March. Fujitsu Aprico, Tokyo, p 79 Nakano I, Maertens G, Major ME, Vitvitski L, Dubuisson J, Fournillier A, De Martynoff G, Trépo C, Inchauspé G (1997) Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode. J Virol 71: 7101–7109 Okada SI, Akahane Y, Suzuki H, Okamoto H, Mishiro S (1992) The degree of variability in the aminoterminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16: 619 Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P (1993) Persistence of hepatitis B and hepatitis C genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology 17: 20 Pertner TM, Roberts TR, Haynes JR (1996) Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol 70: 6119 Prince AM, Brotman B, Huima T, Pascual D, Jaffrey M, Inchauspé G (1992) Immunity in hepatitis C virus infection. J Infect Dis 165: 438 Kolykhalov AA, Agapov EV, Blight KF, Mihalik K, Feinstone SM, Rice CM (1997) Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277: 570–574 Rosa D, Campagnoli S, Moretto C, Cuenzi E, Cousens L, Chin M, Dong C, Weiner AJ, Lau JYN, Choo QL, Chien D, Pileri P, Houghton M, Abrignani S (1996) A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci USA 93: 1759 Rosa D, Ishii K, Miyamura T, Houghton M, Abrigiani S (1977) High titers of envelope neutralizing antibodies correlate with both prevention of HCV infection and resolution of chronic hepatitis C. Abstracts of the Fourth International Meeting on Hepatitis C virus and Related Viruses, Kyoto, 6–10 March. Fujitsu Aprico, Tokyo, p 58 Sekiya H, Kato N, Ootsuyama Y, Nakazawa T, Yamauchi K, Shimotohno K (1994) Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1. Int J Cancer 57: 664 Shirai M, Okada H, Nishioka M, Akatsuka T, Wuchowski C, Houghten R, Pendleton CD, Feinstone SM, Berzofski JA (1994) An epitope in hepatitis C core region recognized by cytotoxic T cells in mice and humans. J Virol 68: 3334 Stingl G, Tschachler E, Groh V, Wolff K, Hauser C (1989) The immune functions of epidermal cells. Immunol Ser 4: 3 Tedeschi V, Akatsuka T, Wai-Kuo Shih J, Battegay M, Feistone SE (1997) A specific antibody response to HCV E2 elicited in mice by intramuscular inoculation of plasmid DNA containing coding sequences for E2. Hepatology 25: 459 Tokushige K, Wakita T, Pachuk C, Moradpour D, Weiner DB, Zurawski VR, and Wands J (1996) Expression and immune response to hepatitis C virus core DNA based vaccine constructs. Hepatology 24: 14 Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgomery DL, Liu MA (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745 Van Doom LJ, Capriles I, Maertens G, DeLeys R, Murray, Kos T, Schellekens H, Hand H, Quint W (1995) Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol 69: 773 Weiner AJ, Brauer MJ, Rosemblatt J, Richman KH, Tung J, Crawford K, Bonino F, Saracco G, Choo QL, Houghton M, Han JH (1991) Variable and bypervariable domains are found in the regions of HCV corresponding to flavivirus envelope and NS1 proteins and the pestivirus envelope proteins. Virology 180: 842 Weiner AJ, Geysens HM, Christopherson C, Hall EJ, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M (1992) Evidence of immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 89: 3468 Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A (1992) Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 6: 363 Zibert A, Schreier E, Roggendorf M (1995) Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208: 653